Advances in Rheumatology

Papers
(The H4-Index of Advances in Rheumatology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil27
Could ultrasound and muscle elastography be associated with clinical assessment, laboratory and nailfold capillaroscopy in juvenile dermatomyositis patients?23
Takayasu’s arteritis associated with tuberculosis: a retrospective study20
Efficacy of two doses of intra-articular ozone therapy for pain and functional mobility in knee osteoarthritis: a double-blind randomized trial19
The effect of rehabilitation protocol using mobile health in overweight and obese patients with knee osteoarthritis: a clinical trial18
Effect of curcumin on the expression of NOD2 receptor and pro-inflammatory cytokines in fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis (RA) patients17
Official Position of the Brazilian Association of Bone Assessment and Metabolism (ABRASSO) on the evaluation of body composition by densitometry—part II (clinical aspects): interpretation, reporting, 17
Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study17
Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?15
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)15
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis15
Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and Safe?15
Comparative study of two laboratory techniques for the detection of HLA-B27 in patients with axial spondyloarthritis: a cross-sectional analysis14
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease14
0.52147889137268